Eric W. Reynolds
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eric W. Reynolds has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Henrietta S. Bada
Department of Pediatrics, Division of Neonatology, University of Kentucky College of Medicine, Lexington
2 shared publicationsAbhijit Patwardhan
1 shared publicationDebbie Grider
1 shared publicationE. T. Conely
University of Kentucky College of Medicine, Kentucky Children’s Hospital
1 shared publicationFrank L. Vice
Michigan State University College of Human Medicine
1 shared publicationGilson Capilouto
1 shared publication
Latest Publications
- 6 July 2010
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 27 (10) , 831-840
Swallow–Breath Interaction and Phase of Respiration with Swallow during Nonnutritive Suck among Low-risk Preterm Infants
This study describes swallow–breath interaction and phase of respiration with swallow during nonnutritive suck (NNS) in low-risk preterm infants. Suckle and swallow, thoracic motion, and airflow were measured in 16 infants during NNS. Logistic regression models were used to describe swallow–breath interaction and phase of respiration with swallow. One hundred seventy-six swallows occurred in 35 NNS periods. Swallow–breath interaction occurred as: central apnea (CA), obstructive apnea (OA), or attenuated respiration (AR). AR was associated with increased weeks post–first nipple feeding. OA occurred less often in males and with increased weeks post–first nipple feeding. In looking at the phase of respiration, more swallows occurred at beginning expiration with increased gestational age, increased weeks post–first nipple feed, and increased weeks before first nipple feed. More swallows occurred at midexpiration with more swallows per study, increased birth weight (BWT), and weeks before first nipple feed. Fewer swallows occurred at end expiration with increased weeks before first nipple feed. Fewer swallows occurred at midinspiration with increased swallows per study. Fewer swallows occurred at apnea with increasing BWT, more occurred with increased swallows per study. In low-risk preterm infants, swallow–breath interaction progresses from CA and OA to AR. The phase of respiration with swallow shows a maturation progression.
- 6 July 2010
- Published by Georg Thieme Verlag KG in American Journal of Perinatology
- Vol. 27 (10) , 831-840
Swallow–Breath Interaction and Phase of Respiration with Swallow during Nonnutritive Suck among Low-risk Preterm Infants
This study describes swallow–breath interaction and phase of respiration with swallow during nonnutritive suck (NNS) in low-risk preterm infants. Suckle and swallow, thoracic motion, and airflow were measured in 16 infants during NNS. Logistic regression models were used to describe swallow–breath interaction and phase of respiration with swallow. One hundred seventy-six swallows occurred in 35 NNS periods. Swallow–breath interaction occurred as: central apnea (CA), obstructive apnea (OA), or attenuated respiration (AR). AR was associated with increased weeks post–first nipple feeding. OA occurred less often in males and with increased weeks post–first nipple feeding. In looking at the phase of respiration, more swallows occurred at beginning expiration with increased gestational age, increased weeks post–first nipple feed, and increased weeks before first nipple feed. More swallows occurred at midexpiration with more swallows per study, increased birth weight (BWT), and weeks before first nipple feed. Fewer swallows occurred at end expiration with increased weeks before first nipple feed. Fewer swallows occurred at midinspiration with increased swallows per study. Fewer swallows occurred at apnea with increasing BWT, more occurred with increased swallows per study. In low-risk preterm infants, swallow–breath interaction progresses from CA and OA to AR. The phase of respiration with swallow shows a maturation progression.
- 1 August 2008
- Published by Springer Nature in Dysphagia
- Vol. 24 (1) , 13-19
Variability of Swallow-associated Sounds in Adults and Infants
We previously used cervical auscultation (CA) to describe the stability of swallow-associated sounds of infant feeding. To date, no similar studies have been performed in adults. The objectives of this study were to identify the initial discrete sounds (IDS) of adult swallows and compare the stability of IDS signals in infants to that of adults. We performed CA with a microphone and accelerometer fixed simultaneously to the neck of 20 healthy adults. Each participant consumed a liquid, puree, and solid. The microphone and accelerometer collected signals of similar duration. The variance index (VI), an assessment of the stability of the IDS, was compared in adults and a group of low-risk preterm infants. The VI of adults swallowing liquid (29.1 [24.1, 36.6] {25%, 75%}) did not differ from that of preterm infants older than 36 weeks PMA (36.3 [33.4, 41.9]), but was lower than the VI of infants younger than 36 weeks PMA (49.0 [46.4, 51.1]; p < 0.05). This is the first real-time comparison of microphones and accelerometers for CA. The stability of IDS of low-risk preterm infants approaches that of normal adults as the infants age. Because successful feeding in infants is often used as a surrogate for normal development, the stability of swallow-associated sounds deserves more investigation as a potential marker for neurologic well-being.
- 1 August 2008
- Published by Springer Nature in Dysphagia
- Vol. 24 (1) , 13-19
Variability of Swallow-associated Sounds in Adults and Infants
We previously used cervical auscultation (CA) to describe the stability of swallow-associated sounds of infant feeding. To date, no similar studies have been performed in adults. The objectives of this study were to identify the initial discrete sounds (IDS) of adult swallows and compare the stability of IDS signals in infants to that of adults. We performed CA with a microphone and accelerometer fixed simultaneously to the neck of 20 healthy adults. Each participant consumed a liquid, puree, and solid. The microphone and accelerometer collected signals of similar duration. The variance index (VI), an assessment of the stability of the IDS, was compared in adults and a group of low-risk preterm infants. The VI of adults swallowing liquid (29.1 [24.1, 36.6] {25%, 75%}) did not differ from that of preterm infants older than 36 weeks PMA (36.3 [33.4, 41.9]), but was lower than the VI of infants younger than 36 weeks PMA (49.0 [46.4, 51.1]; p < 0.05). This is the first real-time comparison of microphones and accelerometers for CA. The stability of IDS of low-risk preterm infants approaches that of normal adults as the infants age. Because successful feeding in infants is often used as a surrogate for normal development, the stability of swallow-associated sounds deserves more investigation as a potential marker for neurologic well-being.
- 1 September 2007
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 46 (7) , 639-645
Neonatal Abstinence Syndrome and Cerebral Infarction Following Maternal Codeine Use During Pregnancy
Neonatal withdrawal from maternal drugs and medications is common in some NICUs. Codeine-containing cough preparations given to pregnant mothers have been identified as a cause of neonatal abstinence syndrome. However, many women do not consider prescription cough syrups when asked about drug use. Maternal medication or illicit drug use has been identified as a cause of perinatal arterial stroke. Since codeine is an opiate with similar pharmacodynamic effects to morphine, it is reasonable to investigate if maternal codeine use has effects on the fetus that are similar to other opiates. The authors present 2 cases of newborn infants with perinatal arterial stroke that may have been associated with in utero exposure to codeine. Physicians should ask about maternal medication use, including codeine-containing cough preparations, when evaluating newborn infants with evidence of cerebral infarction.
- 1 September 2007
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 46 (7) , 639-645
Neonatal Abstinence Syndrome and Cerebral Infarction Following Maternal Codeine Use During Pregnancy
Neonatal withdrawal from maternal drugs and medications is common in some NICUs. Codeine-containing cough preparations given to pregnant mothers have been identified as a cause of neonatal abstinence syndrome. However, many women do not consider prescription cough syrups when asked about drug use. Maternal medication or illicit drug use has been identified as a cause of perinatal arterial stroke. Since codeine is an opiate with similar pharmacodynamic effects to morphine, it is reasonable to investigate if maternal codeine use has effects on the fetus that are similar to other opiates. The authors present 2 cases of newborn infants with perinatal arterial stroke that may have been associated with in utero exposure to codeine. Physicians should ask about maternal medication use, including codeine-containing cough preparations, when evaluating newborn infants with evidence of cerebral infarction.
- 20 March 2007
- Published by Springer Nature in Pediatric Cardiology
- Vol. 28 (3) , 229-233
Nesiritide for the Treatment of Pulmonary Hypertension and Cor Pulmonale in an Infant
Nesiritide is a synthetic form of B-type natriuretic peptide. It is approved for the treatment of acute exacerbations of congestive heart failure in hospitalized adult patients. It is currently under investigation for use in other settings and other patient populations. This article describes administration of nesiritide to an infant patient with severe pulmonary hypertension and cor pulmonale. No adverse reactions occurred during administration of the drug. Specifically, there was no hypertension, vomiting, arrhythmia, or changes in renal function. No changes in renal function occurred in the months subsequent to treatment. This case report illustrates that nesiritide can be safely administered to critically ill infants with pulmonary hypertension and cor pulmonale. Our patient experienced a decrease in pulmonary pressure and improved clinical condition during and after the infusion. However, further study is required to fully evaluate the safety and efficacy of nesiritide for these patients.
- 20 March 2007
- Published by Springer Nature in Pediatric Cardiology
- Vol. 28 (3) , 229-233
Nesiritide for the Treatment of Pulmonary Hypertension and Cor Pulmonale in an Infant
Nesiritide is a synthetic form of B-type natriuretic peptide. It is approved for the treatment of acute exacerbations of congestive heart failure in hospitalized adult patients. It is currently under investigation for use in other settings and other patient populations. This article describes administration of nesiritide to an infant patient with severe pulmonary hypertension and cor pulmonale. No adverse reactions occurred during administration of the drug. Specifically, there was no hypertension, vomiting, arrhythmia, or changes in renal function. No changes in renal function occurred in the months subsequent to treatment. This case report illustrates that nesiritide can be safely administered to critically ill infants with pulmonary hypertension and cor pulmonale. Our patient experienced a decrease in pulmonary pressure and improved clinical condition during and after the infusion. However, further study is required to fully evaluate the safety and efficacy of nesiritide for these patients.
- 1 February 2007
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 119 (2) , 361-369
Nonphysician Clinicians in the Neonatal Intensive Care Unit: Meeting the Needs of Our Smallest Patients
Regional variations in the distribution of neonatal physicians and dependence on housestaff with restricted work hours have created workforce shortages in many NICUs. Although neonatal nurse practitioners assist in the delivery of high-quality care, availability of these providers may be inadequate in certain regions. Physician assistants represent a historically underutilized resource to resolve neonatology's workforce issues. We have developed a postgraduate training program for physician assistants in neonatology that we hope will improve local and regional workforce shortages. In this article we discuss the history of neonatal nurse practitioners and physician assistants in newborn care and outline the program that we developed. We further discuss some of the barriers we had to overcome in developing this program. Our program can serve as a model for other neonatology programs to adequately prepare physician assistants for a career in the NICU.
- 1 February 2007
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 119 (2) , 361-369
Nonphysician Clinicians in the Neonatal Intensive Care Unit: Meeting the Needs of Our Smallest Patients
Regional variations in the distribution of neonatal physicians and dependence on housestaff with restricted work hours have created workforce shortages in many NICUs. Although neonatal nurse practitioners assist in the delivery of high-quality care, availability of these providers may be inadequate in certain regions. Physician assistants represent a historically underutilized resource to resolve neonatology's workforce issues. We have developed a postgraduate training program for physician assistants in neonatology that we hope will improve local and regional workforce shortages. In this article we discuss the history of neonatal nurse practitioners and physician assistants in newborn care and outline the program that we developed. We further discuss some of the barriers we had to overcome in developing this program. Our program can serve as a model for other neonatology programs to adequately prepare physician assistants for a career in the NICU.
- 1 November 2004
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 114 (5) , 1297-1304
Brain-Type Natriuretic Peptide in the Diagnosis and Management of Persistent Pulmonary Hypertension of the Newborn
Objective. The diagnosis of persistent pulmonary hypertension (PPHN) can often be difficult to make, especially in a clinical setting in which pediatric echocardiography is not readily available. A noninvasive test that could differentiate PPHN from other cardiorespiratory disease would be very useful in the early management of the disease, because it would allow rapid identification of those infants at greatest risk of requiring the services of a level 3 nursery. Brain-type natriuretic peptide (BNP) is an endogenous peptide hormone secreted by the cardiac ventricles in response to increased wall stress and related ventricular filling pressures. The purpose of this study was to determine if BNP levels are elevated in newborns with PPHN and therefore may be used as a marker for differentiating PPHN from other forms of respiratory disease during the early newborn period.Method. We used a prospective cohort design with 3 groups. One group was diagnosed with PPHN by clinical and echocardiographic criteria (PPHN group: n = 15). The second group had been diagnosed with respiratory disease; however, PPHN had been ruled out by having no evidence of elevated pulmonary pressure by echocardiography (RD group: n = 17). The third group had no respiratory disease and was breathing room air (RA group: n = 15). BNP levels were measured with a point-of-care fluorescence immunoassay at various time intervals between birth and 150 hours of life.Results. There were no differences between groups for birth weight, gestational age, gender, race, Apgar scores at 1 minute, or age at time of initial blood sampling. Initial BNP levels (pg/mL) were elevated in the PPHN group relative to both the RA and RD groups (median [25%, 75%]: PPHN group = 1610 [1128, 1745]; RD group = 132 [76, 327]; RA group = 248 [127, 395]). There was no difference in the initial BNP level between the RA and RD groups. BNP levels remained elevated in the PPHN group over both groups for the first 4 days of life. BNP levels correlated with the gradient of the tricuspid regurgitation jet and with the ratio of tricuspid regurgitation jet gradient to mean blood pressure. BNP levels were not affected by administration of dopamine or dobutamine. BNP weakly correlated with the oxygenation index but not with the alveolar-arterial oxygenation gradient.Conclusions. Our findings indicate that BNP levels are elevated in infants with PPHN but not in infants with other forms of respiratory distress not associated with PPHN. Elevated BNP levels in term or near-term infants with respiratory distress should increase the suspicion of PPHN. Serial determination may also be helpful in monitoring the clinical course of such infants.
- 1 November 2004
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 114 (5) , 1297-1304
Brain-Type Natriuretic Peptide in the Diagnosis and Management of Persistent Pulmonary Hypertension of the Newborn
Objective. The diagnosis of persistent pulmonary hypertension (PPHN) can often be difficult to make, especially in a clinical setting in which pediatric echocardiography is not readily available. A noninvasive test that could differentiate PPHN from other cardiorespiratory disease would be very useful in the early management of the disease, because it would allow rapid identification of those infants at greatest risk of requiring the services of a level 3 nursery. Brain-type natriuretic peptide (BNP) is an endogenous peptide hormone secreted by the cardiac ventricles in response to increased wall stress and related ventricular filling pressures. The purpose of this study was to determine if BNP levels are elevated in newborns with PPHN and therefore may be used as a marker for differentiating PPHN from other forms of respiratory disease during the early newborn period.Method. We used a prospective cohort design with 3 groups. One group was diagnosed with PPHN by clinical and echocardiographic criteria (PPHN group: n = 15). The second group had been diagnosed with respiratory disease; however, PPHN had been ruled out by having no evidence of elevated pulmonary pressure by echocardiography (RD group: n = 17). The third group had no respiratory disease and was breathing room air (RA group: n = 15). BNP levels were measured with a point-of-care fluorescence immunoassay at various time intervals between birth and 150 hours of life.Results. There were no differences between groups for birth weight, gestational age, gender, race, Apgar scores at 1 minute, or age at time of initial blood sampling. Initial BNP levels (pg/mL) were elevated in the PPHN group relative to both the RA and RD groups (median [25%, 75%]: PPHN group = 1610 [1128, 1745]; RD group = 132 [76, 327]; RA group = 248 [127, 395]). There was no difference in the initial BNP level between the RA and RD groups. BNP levels remained elevated in the PPHN group over both groups for the first 4 days of life. BNP levels correlated with the gradient of the tricuspid regurgitation jet and with the ratio of tricuspid regurgitation jet gradient to mean blood pressure. BNP levels were not affected by administration of dopamine or dobutamine. BNP weakly correlated with the oxygenation index but not with the alveolar-arterial oxygenation gradient.Conclusions. Our findings indicate that BNP levels are elevated in infants with PPHN but not in infants with other forms of respiratory distress not associated with PPHN. Elevated BNP levels in term or near-term infants with respiratory distress should increase the suspicion of PPHN. Serial determination may also be helpful in monitoring the clinical course of such infants.